Impaired Endothelial Dysfunction In Patients With Ankylosing Spondylitis After Covid-19

Authors

  • Madina B. Rakhimova Tashkent Medical Academy

DOI:

https://doi.org/10.62480/tjms.2024.vol39.pp33-40

Keywords:

Ankylosing Spondylitis, COVID-19, Endothelial Dysfunction

Abstract

Currently, there is no doubt about the importance of the role of impaired endothelial functional state in the development of vascular pathology in a number of diseases, including rheumatic. With the advent and largescale spread of a new coronavirus infection (COVID-19), a high rate of patient’s hospitalizations with ankylosing spondyloarthritis (AS) and the development of extrapulmonary complications, such as myocardial injuries, kidney damage and vascular thromboembolism, were noted. The development of this phenomenon confirms the connection with pronounced endothelial dysfunction and its damage. This article presents the results of evaluation of endothelial dysfunction in AS patients undergoing COVID-19.

References

Münzel, T., Sinning, C., Post, F., Warnholtz, A., Schulz, E., Mu¨nzel, T., & Mu¨nzel, M. (2009).

Pathophysiology, diagnosis and prognostic implications of endothelial dysfunction.

https://doi.org/10.1080/07853890701854702.

Sanchez-Piedra, C., Diaz-Torne, C., Manero, J., Pego-Reigosa, J. M., Rúa-Figueroa, Í., Gonzalez-Gay,

M. A., Gomez-Reino, J., & Alvaro-Gracia, J. M. (2020). Clinical features and outcomes of COVID-19 in patients with rheumatic diseases treated with biological and synthetic targeted therapies. Annals of the

Rheumatic Diseases, 79(7), 988–990. https://doi.org/10.1136/annrheumdis-2020-217948.

D’Antiga, L. (2020). Coronaviruses and Immunosuppressed Patients: The Facts During the Third

Epidemic. Liver Transplantation, 26(6), 832–834. https://doi.org/10.1002/lt.25756

Uhrin, Z., Kuzis, S., & Ward, M. M. (n.d.). Exercise and Changes in Health Status in Patients With

Ankylosing Spondylitis. Retrieved August 22, 2021, from https://jamanetwork.com/

Steyers, C. M., & Miller, F. J. (2014). Endothelial Dysfunction in Chronic Inflammatory Diseases. Int.

J. Mol. Sci, 15, 11324–11349. https://doi.org/10.3390/ijms150711324

Liew, J. W., Castillo, M., Zaccagnino, E., Katz, P., Haroon, N., & Gensler, L. S. (2020). Patientreported Disease Activity in an Axial Spondyloarthritis Cohort during the COVID-19 Pandemic. 2(9), 533–

https://doi.org/10.1002/acr2.11174

Roux, C. H., Brocq, O., Gerald, F., Pradier, C., & Bailly, L. (2020). Clinical impact of COVID-19 on

a French population of spondyloarthritis patients. In Clinical Rheumatology (Vol. 39, Issue 11, pp. 3185–

. Springer Science and Business Media Deutschland GmbH. https://doi.org/10.1007/s10067-020-05413-

Vasina, L. V., Petrishchev, N. N., & Vlasov, T. D. (2017). Markers of endothelial dysfunction.

Regional Blood Circulation and Microcirculation, 16(1), 4–15. https://doi.org/10.24884/1682-6655-2017-16-

-4-15

Stolwijk C, Boonen A, van Tubergen A, Reveille JD. Epidemiology of spondyloarthritis. Rheum Dis

Clin North Am. 2012;38:441–76.

Ward M.M, Deodhar A, Gensler LS, Dubreuil M, Yu D, Khan MA, Caplan L. 2019 Update of the

American College of Rheumatology/Spondylitis Association of America/Spondyloarthritis Research and

Treatment Network Recommendations for the Treatment of Ankylosing Spondylitis and Nonradiographic

Axial Spondyloarthritis. Arthritis Rheumatol. 2019 Oct;71(10):1599-1613. doi: 10.1002/art.41042. Epub

Aug 22. PMID: 31436036; PMCID: PMC6764882.

Ciurea A, Kissling S, Bürki K, Baraliakos X, de Hooge M, Hebeisen M, Papagiannoulis E, Exer P,

Bräm R, Nissen MJ, Möller B, Kyburz D, Andor M, Distler O, Scherer A, Micheroli R. Current differentiation

between radiographic and non-radiographic axial spondyloarthritis is of limited benefit for prediction of

important clinical outcomes: data from a large, prospective, observational cohort. RMD Open. 2022

Feb;8(1):e002067. doi: 10.1136/rmdopen-2021-002067. PMID: 35110365; PMCID: PMC8811599.

M.Rakhimova, Kh.Akhmedov, M.Tagaeva, S.Sadikova, F.Razakova, F. Khalmetova. Endothelin-1

biomarker features in patients with ankylosing spondylitis after COVID-19// Journal of positive school

psychology. Vol 6. #6, 2022 p 9369-9375.

Matveeva N.Y., Makarova E.V., Eskin N.A., Sokolova T.V. Consequences of COVID-19 for the

musculoskeletal and peripheral nervous systems. Diagnosis of complications (literature review) // N.N.

Priorov Journal of Traumatology and Orthopedics. - 2022. - Vol. 29. - N. 1. - P. 65-77.

doi: 10.17816/vto105957

Prasad M, Leon M, Lerman LO, Lerman A. Viral Endothelial Dysfunction: A Unifying Mechanism

for COVID-19. Mayo Clin Proc. 2021 Dec;96(12):3099-3108. doi: 10.1016/j.mayocp.2021.06.027. Epub

Aug 19. PMID: 34863398; PMCID: PMC8373818.

Shevchuk S, Pavliuk O. DISORDERS OF STRUCTURAL AND FUNCTIONAL STATE OF BONE

TISSUE IN MEN WITH ANKYLOSING SPONDYLITIS, THEIR RELATION TO DISEASE COURSE.

Wiad Lek. 2021;74(8):1856-1862. PMID: 34537733.

Mahmudiono T. et al. The effect of flaxseed oil consumtion on blood pressure among patients with

metabolic syndrome and related disorders: A systematic review and meta‐analysis of randomized clinical trials

//Phytotherapy Research. – 2022. – Т. 36. – №. 10. – С. 3766-3773.

Rakhimova, M. B., Akhmedov, K. S., & Turaev, Y. A. (2021). Endothelial dysfunction as a link in the

pathogenesis of ankylosing spondylitis against the background of a new coronavirus

infection. ACADEMICIA: An International Multidisciplinary Research Journal, 11(3), 2493-2498

Downloads

Published

2024-12-18

Issue

Section

Articles

How to Cite

Impaired Endothelial Dysfunction In Patients With Ankylosing Spondylitis After Covid-19. (2024). Texas Journal of Medical Science, 39, 33-40. https://doi.org/10.62480/tjms.2024.vol39.pp33-40